INOZYME PHARMA, INC. Prepaid Expense, Noncurrent
INOZYME PHARMA, INC. had Prepaid Expense, Noncurrent of $509.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseNoncurrent · last filed 2025-05-14
- 2025-03-31: Prepaid Expense, Noncurrent $509.00K.
- 2024-12-31: Prepaid Expense, Noncurrent $1.16M.
- 2024-09-30: Prepaid Expense, Noncurrent $458.00K.
- 2024-06-30: Prepaid Expense, Noncurrent $458.00K.
| Period end | Prepaid Expense, Noncurrent |
|---|---|
| 2025-03-31 | $509.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.16M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $458.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $458.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.69M 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.86M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.81M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.81M 10-K · filed 2024-03-12 |
| 2022-09-30 | $3.81M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.81M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.81M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.41M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.07M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.08M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.94M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $3.18M 10-K · filed 2022-03-15 |